TABLE 4.
CAN gene | p-value | Δβ(mean) | β(mean)_normal | β(mean)_tumor |
---|---|---|---|---|
ABCA1 | 7.40E-01 | −0.001 | 0.023 | 0.024 |
ACSL5 | 1.37E-07 | 0.265 | 0.854 | 0.589 |
ADAMTS15 | 1.45E-01 | −0.005 | 0.031 | 0.036 |
ADAMTS18 | 6.86E-01 | 0.014 | 0.252 | 0.238 |
APC | 1.01E-01 | −0.042 | 0.037 | 0.080 |
CD109 | 3.18E-02 | −0.040 | 0.045 | 0.085 |
CHL1 | 5.74E-08 | −0.270 | 0.169 | 0.440 |
CNTN4 | 4.61E-02 | −0.062 | 0.256 | 0.318 |
CSMD3 | 2.21E-04 | −0.156 | 0.070 | 0.227 |
EPHA3 | 1.25E-01 | −0.041 | 0.188 | 0.229 |
EPHB6 | 1.14E-01 | −0.011 | 0.018 | 0.029 |
ERCC6 | 3.06E-01 | −0.003 | 0.019 | 0.022 |
EYA4 | 1.70E-11 | −0.510 | 0.035 | 0.545 |
FBXW7 | 1.44E-01 | 0.006 | 0.084 | 0.078 |
GALNS | 8.73E-01 | 0.000 | 0.029 | 0.029 |
GNAS | 7.05E-01 | −0.012 | 0.526 | 0.538 |
GUCY1A2 | 4.09E-04 | −0.218 | 0.123 | 0.341 |
KCNQ5 | 8.24E-12 | −0.491 | 0.037 | 0.528 |
KRAS | 1.83E-01 | −0.007 | 0.021 | 0.028 |
LRP2 | 4.60E-03 | −0.098 | 0.082 | 0.180 |
MAP2 | 1.23E-03 | −0.104 | 0.379 | 0.483 |
MLL3 | 4.09E-02 | −0.028 | 0.073 | 0.101 |
MMP2 | 1.61E-08 | −0.286 | 0.214 | 0.500 |
NF1 | 2.57E-01 | 0.007 | 0.079 | 0.073 |
PHIP | 3.39E-01 | −0.002 | 0.035 | 0.037 |
PKNOX1 | 8.50E-01 | 0.000 | 0.048 | 0.047 |
PRKD1 | 2.31E-01 | −0.063 | 0.300 | 0.364 |
PTPRU | 8.11E-05 | 0.018 | 0.051 | 0.033 |
RET | 1.39E-02 | −0.107 | 0.075 | 0.182 |
SCN3B | 3.43E-01 | −0.031 | 0.094 | 0.126 |
SFRS6 | 5.15E-02 | −0.004 | 0.028 | 0.031 |
SLC29A1 | 2.49E-01 | 0.003 | 0.055 | 0.052 |
SMAD4 | 5.40E-02 | −0.003 | 0.027 | 0.031 |
TCF7L2 | 7.88E-01 | −0.001 | 0.053 | 0.054 |
TGFBR2 | 2.84E-02 | −0.012 | 0.026 | 0.038 |
UHRF2 | 1.46E-01 | −0.003 | 0.036 | 0.039 |
UQCRC2 | 4.59E-02 | −0.007 | 0.031 | 0.038 |
“CAN genes” are candidate colorectal cancer genes described by Sjoblom et al34.